Keith Wonnacott

Dr. Keith Wonnacott is a seasoned professional with a strong background in Microbiology and Immunology, holding a PhD from Pennsylvania State University College of Medicine and having studied at Brigham Young University.

With a wealth of experience in the pharmaceutical industry, Dr. Wonnacott currently serves as the Executive Director of Regulatory Affairs at Pfizer. Prior to this role, he held the position of Director of Regulatory Affairs, CMC at Novartis, showcasing his expertise in regulatory compliance and drug development.

Dr. Wonnacott has also held distinguished roles in regulatory bodies, having served as the Chief of the Cellular Therapies Branch at the FDA. His tenure at the FDA further solidified his understanding of regulatory processes and ensured compliance with industry standards.

Throughout his career, Dr. Wonnacott has demonstrated a commitment to advancing pharmaceutical regulation and ensuring the safety and efficacy of medical products. His extensive experience in both industry and regulatory agencies makes him a valuable asset in the field of healthcare compliance and regulation.